KUBIX is a biotech startup founded in 2004 that focuses on pioneering precision in biotech with comprehensive reagent kits and advanced genetic analysis services. The company's offerings include contract inspection services, next-generation sequencing analysis, gene expression analysis via microarray, genetic analysis with real-time PCR, and nucleic acid extraction and preparation services. The last investment in KUBIX was a Corporate Round investment on 18 January 2021 led by Toho Holdings. The startup operates in the Biotechnology and Health Care industries, positioning itself as a key player in the advancement of biotech solutions.
No recent news or press coverage available for KUBIX.